Functional profiling of OSP-specific and other antibodies during shigella infection
志贺氏菌感染期间 OSP 特异性抗体和其他抗体的功能分析
基本信息
- 批准号:10468290
- 负责人:
- 金额:$ 76.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-22 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdultAmericanAntibodiesAntibody AffinityAntibody ResponseAntibody titer measurementAntigensAreaAttenuatedBangladeshBindingBiological AssayBiophysicsCessation of lifeChildComplementComplement ActivationConjugate VaccinesDataEnzyme-Linked Immunosorbent AssayEvaluationFc ReceptorFutureGeneral HospitalsGoalsHouseholdHumanImmune responseImmune systemImmunityImmunoglobulin Constant RegionImmunologicsInfectionInnate Immune SystemInstitutesKnowledgeMassachusettsMediatingModelingMorbidity - disease rateMucinsNK Cell ActivationO AntigensOrganismPatternPhagocytesPhagocytosisPlasmidsPlayProcessPublic HealthResearchResearch DesignResearch InstituteResearch PersonnelResource-limited settingResourcesRoleSamplingSampling StudiesShigellaShigella InfectionsShigella VaccinesShigella sonneiSpecificitySystemUniversitiesUrsidae FamilyVaccinatedVaccinationVaccinesValidationVirulence FactorsWorkarmbactericidebasediarrheal diseaseglycosylationinternational centermonocytemortalityneutrophilpathogenresponsevaccine candidatevaccine developmentvaccine evaluationvaccine trialvolunteer
项目摘要
PROJECT SUMMARY/ABSTRACT
Shigella infection is a leading cause of diarrheal illness in young children in resource-limited settings,
and results in tens of thousands of deaths each year. Protection against shigellosis is associated
with antibodies targeting O-specific polysaccharide (OSP), but immune responses against other
antigens have also been noted to correlate with protection. Functional attributes of anti-shigella
antibodies have also been noted to correlate with protection, including complement activation and
ability to induce host cell phagocytic activity. Despite this, a shigella OSP-conjugate vaccine failed to
protect young children in a field trial, despite providing protection in older children and adults. We
propose that such issues may reflect differences not only in antibody magnitude (titer) following
vaccination, but also differences in antibody functional effector attributes, including Fc interactions
with the innate immune system. Such differences have been noted to correlate with protection
against a range of infectious pathogens. To address this, we propose to define antibody functional
and biophysical attributes associated with protection against shigella infection, including in young
children, using a household contact study design approach in an informal settlement area in Dhaka,
Bangladesh. We propose to complement this analysis with data from North American vaccine and
Controlled Human Infection Models (CHIMs) and related studies. We anticipate that we will identify a
profile of antibody attributes that correlates with protection against shigellosis, that this knowledge
will critically guide vaccine development and evaluation efforts, and that this knowledge will focus
future mechanistic studies.
项目摘要/摘要
志贺氏菌感染是在资源有限的环境下幼儿腹泻病的主要原因,
并每年导致成千上万的死亡。保护志核病是相关的
用靶向O特异性多糖(OSP)的抗体,但针对其他的免疫反应
还注意到抗原与保护相关。抗辣椒的功能属性
还注意到抗体与保护相关,包括补体激活和
诱导宿主细胞吞噬活性的能力。尽管如此,一种志贺氏菌OSP结合疫苗未能
尽管为年龄较大的儿童和成人提供保护,但在现场试验中保护幼儿。我们
提出此类问题可能不仅反映了抗体大小(滴度)的差异
疫苗接种,但在抗体功能效应子属性方面的差异,包括FC相互作用
与先天免疫系统。已经注意到这种差异与保护相关
针对一系列感染性病原体。为了解决这个问题,我们建议定义抗体功能
和与志贺氏菌感染有关的生物物理属性,包括在年轻人中
儿童,使用达卡非正式定居区的家庭联系研究设计方法,
孟加拉国。我们建议通过北美疫苗和
受控的人类感染模型(CHIM)和相关研究。我们预计我们将确定
与保护志菌相关的抗体属性的概况,该知识是
将批判性地指导疫苗的开发和评估工作,并且这些知识将集中
未来的机械研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward T. Ryan其他文献
Case 38-2011
案例38-2011
- DOI:
10.1056/nejmcpc1011322 - 发表时间:
2011 - 期刊:
- 影响因子:2.8
- 作者:
Edward T. Ryan;Carmel G. Cronin;John A. Branda - 通讯作者:
John A. Branda
Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice
使用霍乱弧菌减毒疫苗株进行口服免疫,该疫苗株表达与霍乱毒素 B 亚基融合的富含丝氨酸的溶组织内阿米巴蛋白的十二肽重复序列,可诱导全身和粘膜抗阿米巴和抗 V。
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:3.1
- 作者:
Edward T. Ryan;J. Butterton;Tonghai Zhang;Meghan A. Baker;Samuel L. Stanley;Stephen B. Calderwood - 通讯作者:
Stephen B. Calderwood
Case 19-2005
案例19-2005
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
Ann Y. Kao;Rus Munandar;Stephen L. Ferrara;D. M. Systrom;R. Sheridan;Sydney S. Cash;Edward T. Ryan - 通讯作者:
Edward T. Ryan
Case 29-2007
案例29-2007
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
Edward T. Ryan;Suzanne L. Aquino;R. L. Kradin - 通讯作者:
R. L. Kradin
Edward T. Ryan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward T. Ryan', 18)}}的其他基金
Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation
志贺氏菌结合疫苗 (SCV4) 的开发、表征和临床前评估
- 批准号:
10704325 - 财政年份:2023
- 资助金额:
$ 76.19万 - 项目类别:
Functional profiling of OSP-specific and other antibodies during shigella infection
志贺氏菌感染期间 OSP 特异性抗体和其他抗体的功能分析
- 批准号:
10687224 - 财政年份:2020
- 资助金额:
$ 76.19万 - 项目类别:
Functional profiling of OSP-specific and other antibodies during shigella infection
志贺氏菌感染期间 OSP 特异性抗体和其他抗体的功能分析
- 批准号:
10267700 - 财政年份:2020
- 资助金额:
$ 76.19万 - 项目类别:
Functional profiling of OSP-specific and other antibodies during shigella infection
志贺氏菌感染期间 OSP 特异性抗体和其他抗体的功能分析
- 批准号:
10087677 - 财政年份:2020
- 资助金额:
$ 76.19万 - 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
- 批准号:
10598007 - 财政年份:2013
- 资助金额:
$ 76.19万 - 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
- 批准号:
10372233 - 财政年份:2013
- 资助金额:
$ 76.19万 - 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
- 批准号:
10116755 - 财政年份:2013
- 资助金额:
$ 76.19万 - 项目类别:
O-Specific Polysaccharide Responses and Cholera
O 特异性多糖反应和霍乱
- 批准号:
10263266 - 财政年份:2013
- 资助金额:
$ 76.19万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 76.19万 - 项目类别:
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 76.19万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 76.19万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 76.19万 - 项目类别:
Mixed methods examination of warning signs within 24 hours of suicide attempt in hospitalized adults
住院成人自杀未遂 24 小时内警告信号的混合方法检查
- 批准号:
10710712 - 财政年份:2023
- 资助金额:
$ 76.19万 - 项目类别: